F. Tas Et Al. , "Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer," TUMOR BIOLOGY , vol.35, no.4, pp.3611-3616, 2014
Tas, F. Et Al. 2014. Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer. TUMOR BIOLOGY , vol.35, no.4 , 3611-3616.
Tas, F., Karabulut, S., Serilmez, M., Ciftci, R., & Duranyildiz, D., (2014). Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer. TUMOR BIOLOGY , vol.35, no.4, 3611-3616.
Tas, Faruk Et Al. "Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer," TUMOR BIOLOGY , vol.35, no.4, 3611-3616, 2014
Tas, Faruk Et Al. "Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer." TUMOR BIOLOGY , vol.35, no.4, pp.3611-3616, 2014
Tas, F. Et Al. (2014) . "Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer." TUMOR BIOLOGY , vol.35, no.4, pp.3611-3616.
@article{article, author={Faruk TAŞ Et Al. }, title={Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer}, journal={TUMOR BIOLOGY}, year=2014, pages={3611-3616} }